<DOC>
	<DOC>NCT00740246</DOC>
	<brief_summary>The objective of this study is to evaluate the safety and tolerability of VIT-45 in the treatment of Iron Deficiency Anemia</brief_summary>
	<brief_title>Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia, Iron-Deficiency</mesh_term>
	<criteria>Subjects &gt; or = 18 years of age and able to give informed consent Historical laboratory Hgb indicative of anemia within 3 months prior to screening visit Screening Visit laboratory Hgb indicative of anemia Screening Visit ferritin indicative of iron deficiency anemia Known hypersensitivity to VIT45 Previously received VIT45 Parenteral iron in the 4 weeks prior to screening Chronic or serious active infection Malignancy history AST or ALT greater than the upper limit of normal Anticipated need for surgery or initiation of dialysis during the study Pregnant or sexually active females who are not willing to use an effective form of birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>